a novel topical treatment that inhibits DHT on androgen receptors
a potent but unapproved and potentially problematic topical anti-androgen
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
highly targeted anti-androgen that might have minimal systemic effects